The nation of Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (£272m) over five years due to the United States' demand for sensitive information.
This rejection was revealed after a government memo dated December was leaked, revealing that Head of State Emmerson Mnangagwa felt the agreement was "lopsided".
A government representative has since stated that the United States was seeking biological samples for scientific study and profit while refused to guarantee the resulting advantages from future treatments.
"We are forced to start the challenging and unfortunate task of ending our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had donated more than $1.9bn as health assistance to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to secure a agreement agreeable to both sides so the nation's vital HIV programme can proceed.
Wider Background
Zimbabwe's decision follows a comparable case in neighbouring Kenya, where a court suspended a related health funding agreement following concerns were filed about the safety of citizens' medical information.
After resuming office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his government was seeking direct bilateral agreements to enhance openness and responsibility.
Based on reports, Sixteen African countries have so far signed these new agreements, constituting more than $18.3bn in committed funds.
Details of the Declined Agreement
The funds for Zimbabwe would have supported "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Zimbabwe was being asked to provide its genetic material and health information over an extended period, with no equivalent assurance of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," Mangwana explained.
"Put simply, our nation would provide the basic resources for scientific discovery with no certainty that the final treatments would be available to our people if a future disease outbreak arise."
National Interest and Global Health
Mangwana further noted that the American exit from the global health body and its push of one-on-one health agreements were undermining systems previously set up via the international health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential global health emergencies.
"This mechanism is intended to ensure that when a nation contributes its samples, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to develop them."
These objections regarding the US deal "should not be misconstrued as opposition to America," he added.
"We welcome ongoing dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the independence and dignity of each country."
Health Experts Response
Medical experts expressed it recognised the official position, but urged that talks need to persist since much of the country's HIV programmes depended on international support.
"Where technical issues exist, including those involving information security or implementation frameworks, these can frequently be resolved through technical clarification and mutually agreed protections," the group said.
This impasse emphasises the complex tensions between accepting crucial international aid and protecting a country's data in an increasingly data-driven world.